Bührer, Christian http://orcid.org/0009-0007-9006-8787
Paling, Thomas
Gale, Richard
Paulo, Tatiana
Bagijn, Marloes
Article History
Accepted: 3 December 2023
First Online: 4 March 2024
Declarations
:
: Funding was provided by F. Hoffmann-La Roche Ltd. for third-party writing assistance, which was provided by Matthew Glover and Louise Longworth of Putnam PHMR. Funding for open access was provided by F. Hoffmann-La Roche Ltd.
: Christian Bührer is employed by and reports stock ownership in F. Hoffmann-La Roche Ltd. Tatiana Paulo and Marloes Bagijn are employees of F. Hoffmann-La Roche Ltd. Thomas Paling is an employee of Roche Products Ltd. Richard Gale has received financial support from consultancy support from Hoffmann-La Roche Ltd, Novartis and Bayer.
: All data used for this study are provided in the article or are publicly available as indicated by citations.
: Not applicable.
: Not applicable.
: Not applicable.
: The cost-effectiveness model was developed in Microsoft Excel 365 (Microsoft Corporation). Additional information about model programming is available from the corresponding author upon request.
: Conceptualization: Christian Bührer, Thomas Paling, Tatiana Paulo and Marloes Bagijn; methodology: Christian Bührer, Thomas Paling, Tatiana Paulo and Marloes Bagijn; formal analysis and investigation: Christian Bührer, Thomas Paling, Richard Gale, Tatiana Paulo and Marloes Bagijn; writing—review and editing: Christian Bührer, Thomas Paling, Richard Gale, Tatiana Paulo and Marloes Bagijn; funding acquisition: Christian Bührer. All authors read and approved the final manuscript.